Hepatitis B Trial, Recruiting NCT05466565 Sponsor: Xiangya Hospital of Central South University Condition: Hepatitis B
Back to Hepatitis B

Hepatitis B Trial, Recruiting

NCT05466565
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 65 years old (any gender)
  • You have been diagnosed with liver cancer (hepatocellular carcinoma) and have had it treated with surgery to remove the tumour or a procedure called radiofrequency ablation (which uses heat to destroy the tumour)
  • You test positive for the hepatitis B surface antigen (HBsAg), meaning you have a hepatitis B infection
  • During your procedure, doctors confirmed no cancer was left at the edges of the removed tissue, and a scan taken within 4 weeks after your procedure showed no remaining cancer
  • The trial doctor has assessed that you are able to take the medications used in this trial (peginterferon and antiviral tablets)
  • You are willing and able to follow the trial requirements and sign a consent form (or have a legal guardian sign on your behalf if needed)

Who may not be able to join:

  • You are currently taking drugs that can harm the liver, drugs that suppress the immune system, targeted cancer drugs, or chemotherapy after your surgery
  • You have had, or currently have, another type of cancer — except for certain fully treated skin cancers or a very early stage of cervical cancer
  • You have had an allergic reaction to interferon alpha or any of its ingredients, or the trial doctor feels it is not safe for you to take it
  • You have another liver condition alongside hepatitis B, such as hepatitis A, C, D, or E, HIV, alcohol-related liver disease, fatty liver disease, or an autoimmune condition such as autoimmune liver disease or psoriasis
  • Your blood test shows your white blood cell count (neutrophils) or platelet count is too low
  • Your kidney function test (creatinine) result is more than 1.5 times above the normal upper limit
  • You have serious problems with your heart, lungs, kidneys, brain, or blood
  • You have a serious mental health or neurological condition, such as epilepsy, severe depression, mania, schizophrenia, or seizures
  • You have poorly controlled diabetes, high blood pressure, or thyroid problems, or you have significant problems with your eyesight or retina
  • Your liver function is rated as very poor (classified as "Child-Pugh grade C") (confirm with trial site)
  • You have a current problem with drug misuse or heavy alcohol use
  • You had complications after your surgery (such as infection or bleeding) or scans show that your liver cancer has come back or spread
  • You are pregnant, breastfeeding, planning to become pregnant, or unwilling to use contraception during the trial period
  • The trial doctor feels your current health situation makes it unsuitable for you to take part
  • You are already taking part in another clinical trial at the same time

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ledu Zhou, PhD student, Xiangya Hospital of Central South University

Phone: 17373120367

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xiangya Hospital of Central South University
Registry
ClinicalTrials.gov
Start date
1 December 2021
Est. completion
31 October 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

recurrence-free survival time

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov